Stem Cell Therapy and Growth Factor Ovarian in Vitro Activation

Summary

SEGOVA procedure includes - Stem cell therapy, G - Growth factor Platelet Plasma Rich therapy and in Vitro Activation of the ovaries.

Conditions

• Menopause
• Menopause Ovarian Failure
• Ovarian Failure
• Premature Ovarian Failure
• Premature Ovarian Failure 1
• Premature Ovarian Failure 2A
• Premature Ovarian Failure 2B
• Premature Ovarian Failure 3
• Premature Ovarian Failure 4
• Premature Ovarian Failure 5
• Premature Ovarian Failure 6
• Premature Ovarian Failure 7
• Premature Ovarian Failure 8
• Premature Ovarian Failure 9
• Premature Ovarian Failure 10
• Premature Ovarian Failure 11
• Premature Ovarian Failure 12
• Premature Ovarian Failure 13
• Premature Ovarian Failure 14
• Ovarian Insufficiency
• Ovarian Failure Secondary
• Ovarian Failure, Premature
• Ovarian Insufficiency, Primary
• Menopause, Premature

Interventions

COMBINATION_PRODUCT

SEGOVA procedure

SEGOVA procedure includes - Stem cell therapy, G - Growth factor Platelet Plasma Rich therapy and in Vitro Activation of the ovaries.

Sponsors & Collaborators

• Medigroup Health System, Jevremova hospital

  collaborator OTHER

• Saint James Hospital Malta

  collaborator UNKNOWN

• Re-medika Hospital Skoplje

  collaborator UNKNOWN

• Forever Young d.o.o.

  lead OTHER

Principal Investigators

• Aleksandar Ljubic, MD, PhD · Medigroup, Belgrade, Serbia

Study Design

Allocation

NA

Purpose

TREATMENT

Masking

NONE

Model

SINGLE_GROUP

Eligibility

Min Age

25 Years

Sex

FEMALE

Healthy Volunteers

No

Timeline & Regulatory

Start

2019-06-01

Primary Completion

2020-12-31

Completion

2021-12-31

FDA Device

Yes

Countries

• Malta
• North Macedonia
• Serbia

Study Locations